ArticleAsian spine journal2022

Improvements in Intractable Lumbar and LowerExtremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody.

Takeshi Sainoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.